TUESDAY, June 29 (HealthDay News) -- The first generic version
of Effexor extended release capsules (venlafaxine hydrochloride) to
treat major depressive disorder has been approved by the U.S. Food
and Drug Administration.
Prescribing information for the generic version of Effexor XR
may differ from that of the brand name drug because of various
patents held by the brand name drug's maker, Wyeth Pharmaceuticals,
the FDA said in a news release. But the same safety warnings will
apply.
The generic version will be manufactured by Teva
Pharmaceuticals, based in Wales, Penn.
The drug's label includes a warning that antidepressants may
raise the risk of suicidal thoughts or tendencies among some
children, teens and young adults, the agency said.
More information
To learn more about this drug, visit the U.S.
National Library of Medicine.